Paul Gougis

1.6k total citations · 1 hit paper
44 papers, 483 citations indexed

About

Paul Gougis is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Paul Gougis has authored 44 papers receiving a total of 483 indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Oncology, 13 papers in Pulmonary and Respiratory Medicine and 7 papers in Molecular Biology. Recurrent topics in Paul Gougis's work include Cancer Immunotherapy and Biomarkers (11 papers), Cancer Risks and Factors (6 papers) and Lung Cancer Treatments and Mutations (6 papers). Paul Gougis is often cited by papers focused on Cancer Immunotherapy and Biomarkers (11 papers), Cancer Risks and Factors (6 papers) and Lung Cancer Treatments and Mutations (6 papers). Paul Gougis collaborates with scholars based in France, United States and Switzerland. Paul Gougis's co-authors include Joe‐Elie Salem, Christian Funck‐Brentano, Javid J. Moslehi, Arthur Géraud, Bénédicte Lebrun‐Vignes, Fabien Reyal, Floriane Jochum, Anne‐Sophie Hamy, Baptiste Abbar and Olivier Mir and has published in prestigious journals such as Journal of Clinical Oncology, European Heart Journal and American Journal of Obstetrics and Gynecology.

In The Last Decade

Paul Gougis

35 papers receiving 470 citations

Hit Papers

1 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Clinical spectrum and evolution of immune-checkpoint inhibitors toxicities over a decade—a worldwide perspective

2024 67 citations Paul Gougis, Floriane Jochum et al. EClinicalMedicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Paul Gougis France	13	225	96	81	59	52	44	483
Dana J. Nickens United States	12	313 1.4×	179 1.9×	206 2.5×	37 0.6×	28 0.5×	29	678
Takanori Hosokawa Japan	21	115 0.5×	158 1.6×	69 0.9×	26 0.4×	61 1.2×	33	1.2k
Jessica M. van der Bol Netherlands	12	317 1.4×	139 1.4×	100 1.2×	58 1.0×	20 0.4×	24	543
Audrey Bellesœur France	12	283 1.3×	174 1.8×	196 2.4×	32 0.5×	41 0.8×	38	662
Kourosh Parivar United States	9	179 0.8×	133 1.4×	63 0.8×	29 0.5×	111 2.1×	21	649
Jean-Christophe Boyer France	14	219 1.0×	136 1.4×	82 1.0×	43 0.7×	31 0.6×	35	634
Sachin Shah United States	13	286 1.3×	211 2.2×	172 2.1×	50 0.8×	68 1.3×	25	737
Eisei Oda Japan	13	130 0.6×	97 1.0×	40 0.5×	67 1.1×	85 1.6×	27	496
A. D. R. Huitema Netherlands	13	131 0.6×	95 1.0×	59 0.7×	19 0.3×	18 0.3×	26	432

Countries citing papers authored by Paul Gougis

Since Specialization

Citations

This map shows the geographic impact of Paul Gougis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul Gougis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul Gougis more than expected).

Fields of papers citing papers by Paul Gougis

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul Gougis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul Gougis. The network helps show where Paul Gougis may publish in the future.

Co-authorship network of co-authors of Paul Gougis

This figure shows the co-authorship network connecting the top 25 collaborators of Paul Gougis. A scholar is included among the top collaborators of Paul Gougis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul Gougis. Paul Gougis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Dumas, Élise, Floriane Jochum, Florence Coussy, et al.. (2025). Explaining the Relationships Between Age, Endocrine Therapy Persistence, and Risk of Recurrence in Hormone Receptor–Positive Early Breast Cancer: A Nationwide Cohort Study. Journal of Clinical Oncology. 43(16). 1863–1874. 1 indexed citations

Laurent, L. J. M., Baptiste Abbar, Kévin Bihan, et al.. (2025). Comedications Associated with Immune‐Related Adverse Events from Immune‐Checkpoint Inhibitors. Clinical Pharmacology & Therapeutics. 118(3). 593–599. 4 indexed citations

Cabannes‐Hamy, Aurélie, Floriane Jochum, Kévin Bihan, et al.. (2025). BCR::ABL1 Tyrosine Kinase Inhibitors During Pregnancy, a Disproportionality Analysis of Vigibase. Clinical Pharmacology & Therapeutics. 118(3). 705–714.

Gougis, Paul, Floriane Jochum, Baptiste Abbar, et al.. (2024). Clinical spectrum and evolution of immune-checkpoint inhibitors toxicities over a decade—a worldwide perspective. EClinicalMedicine. 70. 102536–102536. 67 indexed citations breakdown →

Géraud, Arthur, et al.. (2024). Safety of solid oncology drugs in older patients: a narrative review. ESMO Open. 9(11). 103965–103965. 1 indexed citations

Jochum, Floriane, Anne‐Sophie Hamy, Paul Gougis, et al.. (2024). Sex-related differences in oncological surgery and postoperative outcomes: comprehensive, nationwide study in France. British journal of surgery. 111(8). 2 indexed citations

Jochum, Floriane, Élise Dumas, Paul Gougis, et al.. (2024). Survival outcomes of primary vs interval cytoreductive surgery for International Federation of Gynecology and Obstetrics stage IV ovarian cancer: a nationwide population-based target trial emulation. American Journal of Obstetrics and Gynecology. 232(2). 194.e1–194.e11. 4 indexed citations

Jochum, Floriane, Florence Coussy, Anne‐Sophie Hamy, et al.. (2024). 234MO Explaining the relationships between age, endocrine therapy persistence and risk of recurrence in hormone-positive early breast cancer: A nationwide cohort study. Annals of Oncology. 35. S310–S310.

Jochum, Floriane, Anne‐Sophie Hamy, Paul Gougis, et al.. (2023). Effects of gender and socio-environmental factors on health-care access in oncology: a comprehensive, nationwide study in France. EClinicalMedicine. 65. 102298–102298. 4 indexed citations

10.

Bihan, Kévin, Corinne Isnard Bagnis, Noël Zahr, et al.. (2023). Management of cancer treatments in hemodialysis patients. Bulletin du Cancer. 111(7-8). 701–719. 2 indexed citations

11.

Dumas, Élise, Florence Coussy, Enora Laas, et al.. (2022). The French Early Breast Cancer Cohort (FRESH): A Resource for Breast Cancer Research and Evaluations of Oncology Practices Based on the French National Healthcare System Database (SNDS). Cancers. 14(11). 2671–2671. 14 indexed citations

12.

Gougis, Paul, Arthur Géraud, Marc Hilmi, et al.. (2022). Cytochrome P-450-mediated herb and food–drug interactions can be identified in cancer patients through patient self-reporting with a tablet application: results of a prospective observational study. ESMO Open. 7(6). 100650–100650. 1 indexed citations

13.

Fenioux, Charlotte, Yves Allenbach, Aurore Vozy, et al.. (2021). Comparaison des caractéristiques et des pronostics des patients avec et sans cancer actif hospitalisés pour une infection à SARS-CoV-2. Bulletin du Cancer. 108(6). 581–588. 3 indexed citations

14.

Gougis, Paul, Fleur Cohen‐Aubart, Luca Campedel, et al.. (2021). Development and clinical validation of a simple and fast UPLC-ESI-MS/MS method for simultaneous quantification of nine kinase inhibitors and two antiandrogen drugs in human plasma: Interest for their therapeutic drug monitoring. Journal of Pharmaceutical and Biomedical Analysis. 197. 113968–113968. 18 indexed citations

15.

Géraud, Arthur, Laura Mezquita, Édouard Auclin, et al.. (2020). Chronic Plasma Exposure to Kinase Inhibitors in Patients with Oncogene-Addicted Non-Small Cell Lung Cancer. Cancers. 12(12). 3758–3758. 3 indexed citations

16.

Salem, Joe‐Elie, Marie Bretagne, Bénédicte Lebrun‐Vignes, et al.. (2019). Clinical characterization of men with long QT syndrome and torsades de pointes associated with hypogonadism: A review and pharmacovigilance study. Archives of cardiovascular diseases. 112(11). 699–712. 16 indexed citations

17.

Gougis, Paul, Lola‐Jade Palmieri, Christian Funck‐Brentano, et al.. (2019). Major pitfalls of protein kinase inhibitors prescription: A review of their clinical pharmacology for daily use. Critical Reviews in Oncology/Hematology. 141. 112–124. 14 indexed citations

18.

Gougis, Paul, et al.. (2017). Clinical pharmacology of anti-angiogenic drugs in oncology. Critical Reviews in Oncology/Hematology. 119. 75–93. 15 indexed citations

19.

Gal, Jocelyn, G. Milano, Jean-Marc Ferrero, et al.. (2017). Optimizing drug development in oncology by clinical trial simulation: Why and how?. Briefings in Bioinformatics. 19(6). 1203–1217. 18 indexed citations

20.

Förster, Martin, R. Mendes, Kevin J. Harrington, et al.. (2016). ORCA-2: A phase I study of olaparib in addition to cisplatin-based concurrent chemoradiotherapy for patients with high risk locally advanced squamous cell carcinoma of the head and neck.. Journal of Clinical Oncology. 34(15_suppl). TPS6108–TPS6108. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact